Back to 
NewEdge Advisors, LLC
NewEdge Advisors, LLC
ETON
Showing 0 of 3 quarters
Position history for NewEdge Advisors, LLC's holdings in Eton Pharmaceuticals, Inc.
No. NewEdge Advisors exited its ETON (Eton Pharmaceuticals) position in Q1 2024. Its Q4 2023 13F listed 252 shares worth $1,103. NewEdge Advisors first reported ETON in Q3 2023 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.